A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine

DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 301–400 of 953

Predicting severity in COVID-19 disease using sepsis blood gene expression signatures
Arjun S. Baghela, Andy An, Peter G. Y. Zhang, Erica Acton, Jeff Gauthier, Elsa Brunet‐Ratnasingham, Travis M. Blimkie, Gabriela Cohen Freue, DE Kaufmann, Amy Huei‐Yi Lee et al. · 2023 · Scientific Reports
Cell‐mediated immunity to SARS‐CoV‐2
Xiaolin Wang, Jingang Gui · 2020 · Pediatric Investigation
Identification of SARS-CoV-2–specific immune alterations in acutely ill patients
Rose‐Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, Audrey Daigneault, Lyne Bourbonnière, Sai Priya Anand, Renaud Balthazard et al. · 2021 · Journal of Clinical Investigation
To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
Francesca Di Rosa, Andrea Cossarizza, Adrian Hayday · 2021 · Frontiers in Immunology
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa
Ben Morton, Kayla G. Barnes, Catherine Anscombe, Khuzwayo C. Jere, Prisca Benedicto-Matambo, Jonathan J. Mandolo, Raphael Kamng’ona, Comfort Brown, James Nyirenda, Tamara Phiri et al. · 2021 · Nature Communications
Attenuated activation of pulmonary immune cells in mRNA-1273–vaccinated hamsters after SARS-CoV-2 infection
Michelle Meyer, Yuan Wang, Darin K. Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, Chad E. Mire, Colette A. Pietzsch, Xi Chen, Yongchao Ge et al. · 2021 · Journal of Clinical Investigation
Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges
Rishabh Mittal, Nidhi Chourasia, Vivek K. Bharti, Snigdha Singh, Poulami Sarkar, Amit Agrawal, Amrita Ghosh, Ranabir Pal, Jagat R. Kanwar, Ashwin Laxmikant Kotnis · 2022 · Journal of Family Medicine and Primary Care
Two for the price of one: itaconate and its derivatives as an anti-infective and anti-inflammatory immunometabolite
Anne F. McGettrick, Luke A.J. O'Neill · 2022 · Current Opinion in Immunology
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Helena Borland Madsen, Jon Ambæk Durhuus, Ove Andersen, Per thor Straten, Anne Rahbech, Claus Desler · 2024 · npj Metabolic Health and Disease
Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms
Rajeev Gupta, Vanya A. Gant, Bryan Williams, Tariq Enver · 2020 · International Journal of Infectious Diseases
Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures
Gajanan Sampatrao Ghodake, Surendra Krushna Shinde, Avinash Ashok Kadam, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Asad Syed, Abdallah Mohamed Elgorban, Najat Marraiki, Dae-Young Kim · 2021 · Biosensors and Bioelectronics
Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities
Tiantian Yan, Rong Xiao, Nannan Wang, Ruoyu Shang, Guoan Lin · 2021 · Theranostics
Immune-Guided Therapy of COVID-19
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte · 2022 · Cancer Immunology Research
Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Mary Ann Hausner, Jennifer A. Fulcher, Paul A Krogstad, Kathie G. Ferbas, Nicole H. Tobin, Anne W. Rimoin, Grace M. Aldrovandi et al. · 2022 · Frontiers in Immunology
Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
Hongye Wang, Dongshan Yan, Ya Li, Yanfei Gong, Yulin Mai, Bingxiang Li, Xiaoyong Zhu, Xinrui Wan, Liyun Xie, HuaKe Jiang et al. · 2022 · Infectious Diseases of Poverty
Does inflammation link stress to poor COVID‐19 outcome?
Steven J. Lamontagne, Diego A. Pizzagalli, Mary C. Olmstead · 2020 · Stress and Health
T cell phenotypes in COVID-19 - a living review
Stephanie Jean Hanna, Amy Susan Codd, Ester Gea‐Mallorquí, David Oliver Scourfield, Felix Clemens Richter, Kristin Ladell, Mariana Borsa, Ewoud Bernardus Compeer, Owen R. Moon, Sarah A. E. Galloway et al. · 2020 · Oxford Open Immunology
COVID 19: in the eye of the cytokine storm
Giovanna Liuzzo, Carlo Patrono · 2020 · European Heart Journal
Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19
Nabil T. Fadai, Rahil Sachak-Patwa, Helen Mary Byrne, Philip K. Maini, Mona Bafadhel, Dan V. Nicolau · 2021 · Journal of The Royal Society Interface
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
Danyang Liu, Jiachen Liu, Shuang Liang, Xiang‐He Meng, Jonathan Greenbaum, Hong‐Mei Xiao, Lijun Tan, Hong‐Wen Deng · 2021 · Pharmaceutics
Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage
Nagavalli Pillalamarri, Abdullah Abdullah, Gang Ren, Luqman Khan, Asad Ullah, Sriya T. Jonnakuti, Mujib Ullah · 2021 · Translational Oncology
ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points
Álvaro Tamayo-Velasco, María Jesús Peñarrubia-Ponce, Francisco Javier Álvarez, Ignacio de la Fuente, Sonia Pérez González, David Andaluz‐Ojeda · 2022 · Frontiers in Medicine
Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos J. Milionis, George Ν. Dalekos, Vasileios Petrakis, Styliani Sympardi, Symeon Metallidis et al. · 2022 · International Journal of Molecular Sciences
Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, Michele Siqueira, Anne Caroline Marcos, Marialice Heider, Caroline Soares Motta, Silvia Torices, Michal J. Toborek, Joice Stipursky · 2022 · Fluids and Barriers of the CNS
Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial
Matthew Fish, Jennifer Rynne, A.R. Jennings, C Lam, Abigail Lamikanra, Jeremy D. Ratcliff, Silvia Cellone Trevelin, Emma M. Timms, J. Jiriha, Isabella Tosi et al. · 2022 · Intensive Care Medicine
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
Raahilah Zahir Essa, Yuan Seng Wu, Kalaivani Batumalaie, Mahendran Sekar, Chit Laa Poh · 2022 · Pharmacological Reports
Plasma markers of COVID-19 severity: a pilot study
Julia Beimdiek, Sabina M Janciauskiene, Sabine Wrenger, Sonja Volland, Adriana Roży, Jan Fuge, Beata T. Olejnicka, Isabell Pink, Thomas Illig, Alexander Popov et al. · 2022 · Respiratory Research
The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations
Francisco José Barrantes · 2021 · Brain Behavior & Immunity - Health
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
Tanveer Ahmad, Rituparna Chaudhuri, Mohan Chandra Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali · 2020 · Frontiers in Microbiology
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney B. Woolsey, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert · 2021 · Cell Reports
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
Esperanza Martín‐Sánchez, Juan‐José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Dı́az de Cerio, Francisco Carmona-Torre, Marta Marín‐Oto, Félix Alegre, Elvira Molano, Mirian Fernández-Alonso et al. · 2021 · Frontiers in Immunology
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression
Liam Townsend, Adam H. Dyer, Aifric Naughton, Sultan Imangaliyev, Jean Dunne, Rachel Kiersey, Dean Holden, Aoife Mooney, Deirdre Leavy, Katie Ridge et al. · 2022 · Heliyon
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population
Ilse Adriana Gutiérrez-Pérez, Ivette Buendía-Roldán, Gloría Pérez-Rubio, Leslie Chávez‐Galán, Rafael de Jesús Hernández-Zenteno, Hiram Aguilar‐Duran, Ingrid Fricke-Galindo, Óscar Zaragoza-García, Ramcés Falfán‐Valencia, Iris Paola Guzmán‐Guzmán · 2022 · Frontiers in Medicine
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
Shiyu Liu, Wenjuan Luo, Peter Szatmary, Xiaoying Zhang, Jingwen Lin, Lu Chen, Dan Liu, Robert Sutton, Qing Xia, Tao Jin et al. · 2023 · International Journal of Molecular Sciences
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose et al. · 2021
Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19
Shukur Wasman Smail, Niaz Albarzinji, Rebaz Hamza Salih, Kalthum Othman Taha, Sarah Mousa Hirmiz, Hero M. Ismael, Marwa Fateh Noori, Sarkar Sardar Azeez, Christer Janson · 2025 · Frontiers in Cellular and Infection Microbiology
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension
Qiang Zeng, Yongzhe Li, Sheng-Yong Dong, Zongtao Chen, Xiangyang Gao, Han Zhang, Gang Huang, Yang Xu · 2020 · Frontiers in Immunology
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Johann Sellner, Paulus Stefan Rommer · 2021 · Vaccines
Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points
Lucía Pinilla, Ivan David Benitez, Jessica González, Gerard Torres, Ferrán Barbé, David de Gonzalo‐Calvo · 2021 · RNA Biology
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
Eugenia Ziying Ong, Shirin Kalimuddin, Wen Chong Chia, Sarah H Ooi, Clara WT Koh, Hwee Cheng Tan, Summer Li-Xin Zhang, Jenny Guek Hong Low, Eng Eong Ooi, Kuan Rong Chan · 2021 · EBioMedicine
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
Pankaj Kumar Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis Kumar Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Frontiers in Immunology
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
Elisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, Linda Petrone, Valentina Vanini, Gilda Cuzzi, Gina Gualano, Luca Pierelli, Antonio Bertoletti, Emanuele Nicastri et al. · 2021 · Journal of Translational Medicine
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
Sergio Gil-Manso, Iria Miguéns Blanco, Rocío López-Esteban, Diego Carbonell, Luis Andrés López-Fernández, Lori J. West, Rafael Correa‐Rocha, Marjorie Pion · 2022 · Frontiers in Immunology
Cancer Occurrence as the Upcoming Complications of COVID-19
Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard · 2022 · Frontiers in Molecular Biosciences
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
Max Luedemann, Daniela Stadler, Cho‐Chin Cheng, Ulrike Protzer, Percy Alexander Knolle, Sainitin Donakonda · 2022 · Computational and Structural Biotechnology Journal
Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation
Elizabeth S. Taglauer, Yashoda V. Dhole, Jeffery O. Boateng, Jennifer E Snyder-Cappione, Samantha E. Parker, Katherine Clarke, Lillian J. Juttukonda, Jean L. Devera, Jessica Hunnewell, Elizabeth D. Barnett et al. · 2022 · Journal of Perinatology
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2022 · Frontiers in Immunology
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
Kuan Rong Chan, Clara WT Koh, Dorothy Hui Lin Ng, Shijie Qin, Justin S. G. Ooi, Eugenia Ziying Ong, Summer L.X. Zhang, Huizhen Sam, Shirin Kalimuddin, Jenny Guek Hong Low et al. · 2023 · EBioMedicine
No Small Matter: A Perspective on Nanotechnology-Enabled Solutions to Fight COVID-19
Georgia Wilson Jones, Marco P. Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel · 2020 · Nanomedicine
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden Terry Maecker · 2021 · Journal for ImmunoTherapy of Cancer
Monocyte and dendritic cell defects in COVID-19
Andreas Wack · 2021 · Nature Cell Biology
CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, Aurélien Corneau, Karim Dorgham, Makoto Miyara, Charles Edouard Luyt et al. · 2021 · JCI Insight
Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression
Jin Li, Jinli Wei, Zhixiang Xu, Chunmei Jiang, Mianhuan Li, Jie Chen, Yanjie Li, Ming‐Hui Yang, Yuchen Gu, Fuxiang Wang et al. · 2021 · Frontiers in Immunology
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic
Alessandro Russo, Vincenzo Olivadese, Enrico Maria Trecarichi, Carlo Torti · 2022 · Journal of Clinical Medicine
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness
Eric D. Morrell, Pavan K. Bhatraju, Neha Alhad Sathe, Jonathan J. Lawson, L. Mabrey, Sarah E. Holton, Scott Presnell, ALICE E. WIEDEMAN, Carolina Acosta‐Vega, Mallorie A. Mitchem et al. · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Francis R. Hopkins, Melissa Govender, Cecilia Svanberg, Johan Nordgren, Hjalmar Waller, Åsa Nilsdotter‐Augustinsson, Anna Jonsson Henningsson, Marie Hagbom, Johanna Sjöwall, Sofia N. Nyström et al. · 2023 · Frontiers in Immunology
Strategies for Immunomonitoring after Vaccination and during Infection
Lucille Adam, Pierre Rosenbaum, Olivia Bonduelle, Béhazine Combadière · 2021 · Vaccines
Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Thundon Ngamprasertchai, Rattagan Kajeekul, Chaisith Sivakorn, Narisa Ruenroengbun, Viravarn Luvira, Tanaya Siripoon, Nantasit Luangasanatip · 2021 · Infectious Diseases and Therapy
Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
Dana Rose Julian, Megan A. Kazakoff, Akhil Patel, Jesse M. Jaynes, Monte S. Willis, Cecelia Chrsitina Yates · 2021 · Current Pathobiology Reports
Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
Gethsimani Papadopoulou, Eleni Manoloudi, Nikolena Repousi, Lemonia Skoura, Tara Patricia Hurst, Timokratis Karamitros · 2022 · Pathogens
Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
Kai Jakobs, Leander Reinshagen, Marianna Puccini, Julian Friebel, Anne‐Christin Beatrice Wilde, Ayman Alsheik, Andi Rroku, Ulf Landmesser, Arash Haghikia, Nicolle Kränkel et al. · 2022 · Frontiers in Immunology
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
Germana Grassi, Stefania Notari, Simona Gili, Veronica Bordoni, Rita Casetti, Eleonora Cimini, Eleonora Tartaglia, Davide Mariotti, Chiara Agrati, Alessandra Sacchi · 2022 · Frontiers in Immunology
Chemokine Regulation During Epidemic Coronavirus Infection
Shamik Majumdar, Philip M. Murphy · 2021 · Frontiers in Pharmacology
Endothelial PPARδ Ablation Exacerbates Vascular Hyperpermeability via STAT1/CXCL10 Signaling in Acute Lung Injury
Huiling Hong, Yalan Wu, Yangxian Li, Yumeng Han, Xiaoyun Cao, Vivian Wei Yan Wu, Thomas Ting Hei Chan, Jingying Zhou, Qin Cao, Kathy O. Lui et al. · 2025 · Circulation Research
Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infection
Radha Yadav, Arup Acharjee, Akanksha Salkar, Renuka Bankar, Viswanthram Palanivel, Sachee R Agrawal, Jayanthi S. Shastri, Sanjeev V. Sabnis, Sanjeeva Srivastava · 2021 · EClinicalMedicine
SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
Vimvara Vacharathit, Sirawat Srichatrapimuk, Suwimon Manopwisedjaroen, Suppachok Kirdlarp, Chanya Srisaowakarn, Chavachol Setthaudom, Nanthicha Inrueangsri, Prapaporn Pisitkun, Mongkol Kunakorn, Suradej Hongeng et al. · 2021 · International Journal of Infectious Diseases
SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10
André M. C. Gomes, Guilherme B. Farias, Manuel Dias‐Silva, Joel Laia, Amelia Chiara Trombetta, Ana Godinho‐Santos, Pedro Rosmaninho, Diana F. Santos, Carolina M. Conceição, Renato Costa‐Reis et al. · 2021 · European Journal of Immunology
Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults
Sloan A. Lewis, Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Izabela Coimbra Ibraim, Amanda N. Pinski, Nicholas S. Rhoades, Micaila Curtis, Xiwen Jiang et al. · 2021 · Nature Aging
Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease
Taru S. Dutt, Stephanie M LaVergne, Tracy L Webb, Bridget A Baxter, Sophia Stromberg, Kim McFann, Kailey Berry, Madison Tipton, Omar Alnachoukati, Linda Zier et al. · 2022 · The Journal of Immunology
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Dóra Bencze, Tünde Fekete, Kitti Pázmándi · 2022 · International Journal of Molecular Sciences
Quantifying stimulus-response specificity to probe the functional state of macrophages
Katherine M. Sheu, Aditya A. Guru, Alexander Hoffmann · 2023 · Cell Systems
Single-cell multi-omics topic embedding reveals cell-type-specific and COVID-19 severity-related immune signatures
Manqi Zhou, Hao Zhang, Zilong Bai, Dylan Mann‐Krzisnik, Fei Wang, Yue Li · 2023 · Cell Reports Methods
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity
Elsa Brunet‐Ratnasingham, Sacha Morin, Haley E. Randolph, Marjorie Labrecque, Justin Bélair, Raphaël Lima-Barbosa, Amélie Pagliuzza, Lorie Marchitto, Michael Hultström, Julia Niessl et al. · 2024 · Nature Communications
Upregulation of the Renin–Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients
Loris Zamai · 2021 · Cells
Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19
Nasna Nassir, Richa Tambi, Asma Bankapur, Saba Al Heialy, Noushad S. Karuvantevida, Hamda Hassan Khansaheb, Binte Zehra, Ghausia Begum, Reem Abdel Hameid, Awab Ahmed et al. · 2021 · iScience
Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities
Chang-Feng Chu, Florian Sabath, Silvia Fibi-Smetana, Shan Sun, Rupert Öllinger, Elfriede Noeßner, Ying-Yin Chao, Linus Rinke, Elena Winheim, Roland Rad et al. · 2021 · Frontiers in Immunology
Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform
Md. Azahar Ali, Fei Zhang, Chunshan Hu, Bin Yuan, Sanjida Jahan, Georgios D. Kitsios, Alison M. Morris, Shou‐Jiang Gao, Rahul P. Panat · 2022 · Journal of Medical Virology
Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID
Md Sahidul Islam, Zhaoxiong Wang, Mohamed Abdel‐Mohsen, Xin Chen, Luis J. Montaner · 2023 · Journal of Leukocyte Biology
Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease
Chunsong Hu · 2024 · Natural Products and Bioprospecting
Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis
Mark R. Jackson, Katrina H. Stevenson, Sandeep K. Chahal, Emer Curley, George E. Finney, Rodrigo Gutierrez‐Quintana, Evarest Onwubiko, Angie Rupp, Karen E. Strathdee, Karin Williams et al. · 2021 · International Journal of Radiation Oncology*Biology*Physics
Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements
Paulina A García-González, Fabián Tempio, Camila Fuentes, Consuelo Merino, Leonardo Vargas, Valeska Simon, Mirliana Ramírez-Pereira, Veronica A. Rojas, Eduardo A. Tobar, Glauben Landskron et al. · 2021 · Frontiers in Immunology
N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
Javier Milara, Fernando Martínez‐Expósito, Paula Montero, Inés Roger, María Amparo Bayarri, Pilar Ribera, Miriam Natsuki Oishi-Konari, Jose Ramón Alba-García, Enrique Zapater, Julio Cortijo · 2022 · International Journal of Molecular Sciences
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
Jennifer R. Habel, Brendon Yew Loong Chua, Łukasz Kedzierski, Kevin John Selva, Timon Damelang, Ebene R. Haycroft, Thi H. O. Nguyen, Hui‐Fern Koay, Suellen R Nicholson, Hayley A. McQuilten et al. · 2023 · JCI Insight
Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
Walter Conca, Mayyadah H. Alabdely, Faisal A. Albaiz, Michael Warren Foster, Maha Al‐Amri, Morad Ahmed Alkaff, Futwan A Al-Mohanna, Nicolaas J. D. Nagelkerke, Reem Saad Almaghrabi · 2021 · PLoS ONE
Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia
Alex R. Schuurman, Tom D. Y. Reijnders, Anno Saris, Ivan Ramirez‐Moral, Michiel Schinkel, Justin de Brabander, Christine C. A. van Linge, Louis Vermeulen, Brendon P. Scicluna, Willem Joost Wiersinga et al. · 2021 · eLife
Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19
Sueva Cantalupo, Vito Alessandro Lasorsa, Roberta Russo, Immacolata Andolfo, Giuseppe D’Alterio, Barbara Eleni Rosato, Giulia Frisso, Pasquale Abete, Gian Marco Cassese, Giuseppe Servillo et al. · 2021 · International Journal of Molecular Sciences
Complement Inhibition and COVID-19: The Story so Far
Sofiane Fodil, Djillali Annane · 2021 · ImmunoTargets and Therapy
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19
Magdalene Joseph, Yin Wu, Richard Dannebaum, Florian Rubelt, Iva Zlatareva, Anna Lorenc, Zhipei Gracie Du, Daniel Davies, Fernanda Kyle‐Cezar, Abhishek Das et al. · 2022 · Proceedings of the National Academy of Sciences
Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies
Hongyang Shu, Chunxia Zhao, Dao Wen Wang · 2023 · Cardiology Plus
An Impaired Inflammatory and Innate Immune Response in COVID-19
Sung Ho Park · 2021 · Molecules and Cells
Covid-19 controversies: the tocilizumab chapter
Erin K McCreary, Nuala J. Meyer · 2021 · BMJ
Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
Isaac Kyei-Barffour, Samuel Akwetey Addo, E. Aninagyei, George Ghartey-Kwansah, D. O. Acheampong · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract
Hae Eun Noh, Min‐Seok Rha · 2024 · Pathogens
Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort
Koji Abe, Joanne C. Beer, Tran Thuy Nguyen, Ishara S. Ariyapala, Tyson H. Holmes, Wei Feng, Bingqing Zhang, Dwight Kuo, Yuling Luo, Xiao-Jun Ma et al. · 2024 · The Journal of Immunology
Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries
Asim Hussain, Hamza Rafeeq, Hafiza Memoona Asif, Sumaira Shabbir, Muhammad Bilal, Sikandar Imamsab Mulla, Marcelo Franco, Hafiz M.N. Iqbal · 2021 · International Immunopharmacology
People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden
Anthony Richard Cillo, Ashwin Somasundaram, Feng Shan, Carly Cardello, Creg J. Workman, Georgios D. Kitsios, Ayana T. Ruffin, Sheryl R. Kunning, Caleb Lampenfeld, Sayali Onkar et al. · 2021 · Cell Reports Medicine
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Rachel M. Y. Cheong, Anusha Yellapragada, Wey Y. Wong, Yi Tian Ting, Julie A. Monk, Poh‐Yi Gan, Stephen Roger Holdsworth et al. · 2022 · Frontiers in Immunology
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Yoshitomo Morinaga, Yoshihiro Yamamoto · 2022 · Frontiers in Immunology
Circulating proteins to predict COVID-19 severity
Chen‐Yang Su, Sirui Zhou, Edgar Gonzalez‐Kozlova, Guillaume Butler‐Laporte, Elsa Brunet‐Ratnasingham, Tomoko Nakanishi, Wonseok Jeon, David Morrison, Laetitia Laurent, Jonathan Afilalo et al. · 2023 · Scientific Reports
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Peter A. C. Wing, Nathalie M. Schmidt, Rory Peters, Maximilian Erdmann, Rachel L. Brown, Hao Wang, Leo Swadling, COVIDsortium Investigators, Joseph Newman, Nazia Thakur et al. · 2023 · PLoS Pathogens